Crafting a more efficient car t-cell industry

被引：0
|
作者：
Raper V.
机构：
来源：
Genetic Engineering and Biotechnology News | 2019年 / 39卷 / 05期
关键词：
D O I：
10.1089/gen.39.05.09
中图分类号：
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：24 / 26and28
页数：2604
相关论文
共 50 条
  • [41] Filgrastim associations with CAR T-cell therapy
    Gaut, Daria
    Tang, Kevin
    Sim, Myung Shin
    Tuyen Duong
    Young, Patricia
    Sasine, Joshua
    INTERNATIONAL JOURNAL OF CANCER, 2021, 148 (05) : 1192 - 1196
  • [42] CAR T-cell therapy for multiple myeloma
    Zhou, X.
    Einsele, H.
    Danhof, S.
    INTERNIST, 2021, 62 (06): : 605 - 610
  • [43] CAR T-cell hematotoxicity is inflammation the key?
    Faram, Rawan G.
    Davila, Marco L.
    BLOOD, 2021, 138 (24) : 2447 - 2448
  • [44] Managing the toxicities of CAR T-cell therapy
    Neelapu, Sattva S.
    HEMATOLOGICAL ONCOLOGY, 2019, 37 : 48 - 52
  • [45] CAR T-Cell Therapy: Progress and Prospects
    Wilkins, Olivia
    Keeler, Allison M.
    Flotte, Terence R.
    HUMAN GENE THERAPY METHODS, 2017, 28 (02) : 61 - 66
  • [46] Hematopathologic Correlates of CAR T-Cell Therapy
    Dolan, J. Gregory
    Paessler, Michele E.
    Rheingold, Susan R.
    Pillai, Vinodh
    CLINICS IN LABORATORY MEDICINE, 2021, 41 (03) : 325 - 339
  • [47] CAR T-cell therapy: opportunities and challenges
    Zhang, Wenlong
    IMMUNOTHERAPY, 2016, 8 (03) : 245 - 247
  • [48] CAR T-cell therapy in autoimmune diseases
    Schett, Georg
    Mackensen, Andreas
    Mougiakakos, Dimitrios
    LANCET, 2023, 402 (10416): : 2034 - 2044
  • [49] CAR T-Cell Therapy for Ovarian Cancer
    Yeku, Oladapo
    ONCOLOGIST, 2018, 23 : S3 - S3
  • [50] CAR T-cell Characteristics Determine Efficacy
    Leslie, Mitch
    CANCER DISCOVERY, 2020, 10 (12) : 1780 - 1780
12345